Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Financing Activities (2016 - 2025)

Haemonetics (HAE) has 17 years of Cash from Financing Activities data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 47.32% year-over-year to $2.0 million; the TTM value through Dec 2025 reached -$228.4 million, down 216.08%, while the annual FY2025 figure was $108.8 million, 185.18% up from the prior year.
  • Cash from Financing Activities reached $2.0 million in Q4 2025 per HAE's latest filing, up from -$76.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $432.8 million in Q2 2021 and bottomed at -$151.4 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is $19.3 million, with a median of -$2.9 million recorded in 2021.
  • The widest YoY moves for Cash from Financing Activities: up 55901.34% in 2024, down 3861.45% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$3.3 million in 2021, then tumbled by 1398.64% to -$49.7 million in 2022, then surged by 320.27% to $109.4 million in 2023, then plummeted by 98.74% to $1.4 million in 2024, then skyrocketed by 47.32% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $2.0 million in Q4 2025, -$76.6 million in Q3 2025, and -$2.4 million in Q2 2025.